医学
肝损伤
重症监护医学
药品
风险分析(工程)
药理学
作者
Helgi K. Björnsson,Einar S. Björnsson
标识
DOI:10.1080/17425255.2023.2288260
摘要
Great advances have been made in identifying genetic risk factors for DILI. Combining these risk factors with demographic information and other biomarkers into multigenetic risk models might become highly useful in risk stratifying patients exposed to DILI. However, a more detailed mapping of genetic risk factors is needed. Results of these studies need to be validated in the selected ethnic groups before applicability and cost-effectiveness can be determined.
科研通智能强力驱动
Strongly Powered by AbleSci AI